Navigation Links
MIGENIX Reports Second Quarter Fiscal Year 2008 Financial Results
Date:12/13/2007

out MIGENIX

MIGENIX is committed to advancing therapy, improving health, and enriching life by developing and commercializing drugs primarily in the area of infectious diseases. The Company's clinical programs include drug candidates for the treatment of chronic hepatitis C infections (Phase II and preclinical), the prevention of catheter-related infections (Phase III) and the treatment of dermatological diseases (Phase II). MIGENIX is headquartered in Vancouver, British Columbia, Canada with US operations in San Diego, California. Additional information can be found at http://www.migenix.com.

"Jim DeMesa"

------------

James M. DeMesa, M.D.

President & CEO

FORWARD-LOOKING STATEMENTS

This news release contains forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995, and forward-looking information within the meaning of applicable securities laws in Canada, (collectively referred to as "forward-looking statements"). Statements, other than statements of historical fact, are forward-looking statements and include, without limitation, statements regarding our strategy, future operations, timing and completion of clinical trials, prospects, plans and objectives of management. The words "anticipates", "believes", "budgets", "could", "estimates", "expects", "forecasts", "intends", "may", "might", "plans", "projects", "schedule", "should", "will", "would" and similar expressions are often intended to identify forward-looking statements, which include underlying assumptions, although not all forward-looking statements contain these identifying words. By their nature, forward-looking statements involve numerous assumptions, known and unknown risks and uncertainties, both general and specific, that contribute to the possibility that the predictions, forecasts, projections and other things contemplated by the forward-lo
'/>"/>

SOURCE MIGENIX Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related biology technology :

1. MIGENIX First Fiscal Quarter 2008 Financial Results Conference Call & Webcast Notification
2. MIGENIX to Present Positive Celgosivir Viral Resistance Data at International HCV Meeting
3. MIGENIX Reports First Quarter Fiscal Year 2008 Financial Results
4. MIGENIX to Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
5. MIGENIX Second Fiscal Quarter 2008 Financial Results Conference Call & Webcast Notification
6. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
7. QMed, Inc. Reports July Medicare SNP Enrollments
8. Phlo Affiliate Reports Expanded Coverage to Oregon Border
9. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
10. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
11. Carrington Reports Second Quarter 2007 Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...hfirmReplikinsLtd.,whichhasanalyzedtheH1N1virus,ge...utbreak,andprogressofthecurrentH1N1pandemic,todayi...datashowsthatthelethalityoftheH1N1("SwineFlu")viru...,scurrentoutbreakinthespringof2009torestingnon-epi...ectivitycount,however,remainsincreased. ,, Then...
(Date:11/25/2009)...tlinker.comannouncesthatanewmarketresearchreportis...rketAnalysisandForecaststo2013 ,, http://www....-Analysis-and-Forecasts-to-2013.html ,, Brazil...Summary ,, Thereportprovidesdetailedanalysisan...ioethanolmarketinparticular.Italsohelpsinanalyzing...
(Date:11/24/2009)...vestment bank KTA Capital,s client Neuren Pharmace...vertible note private placement with a U.S. instit...ed by KTA Capital as Neuren,s exclusive placement ...York (PRWEB) November 23, 2009 -- The independent ...TA Capital") has announced that its client Ne...
(Date:11/24/2009)...ployment grew by 29,000 jobs in October, and the ...th during the U.S. recession. However, clinics and... systems are coming closer to having to actually c...rs. , (Vocus) November 24... in October despite the shedding of jobs in most o...
Breaking Biology Technology:Biological H1N1 Vaccines: Too Little, Too Late 2Biological H1N1 Vaccines: Too Little, Too Late 3Biological H1N1 Vaccines: Too Little, Too Late 4Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 2Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 3Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 4Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 5Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 6Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 7Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 8Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 9KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4
...poration (Pink Sheets: MNCN), a global health comp...r positive, long term benefit to the agricultural ...closed on the acquisition of Modular Process Const...the LLC interests of MPC for $500,000 of Series B ...of $0.50 cents per share. The purchase price was f...
...ray Incorporated,(Nasdaq: ARAY ), a global leade...at 10 percent of its U.S. installed base has signe...ervice. Treatment planning by medical physicists,i...adiosurgery treatment,delivery. , Accuray,s tr...mers,maximize utilization of their CyberKnife Syst...
... announced today,that Scopus(R), its flagship prod...mp;C) database, was chosen by the Australian Resea...or Australia (ERA) initiative. , The ERA initi...a,s higher,education institutions using a combinat...comprised of experienced, internationally-recogniz...
Other Biology Technology:Mach One Closes on Acquisition of Biopharmaceutical Design & Engineering Firm 210 Percent of U.S. Installed Base Signs on to Use Accuray Treatment Planning Service 210 Percent of U.S. Installed Base Signs on to Use Accuray Treatment Planning Service 310 Percent of U.S. Installed Base Signs on to Use Accuray Treatment Planning Service 4The Australian Research Council Selects Scopus for the Evaluation of the Australian Research Landscape 2The Australian Research Council Selects Scopus for the Evaluation of the Australian Research Landscape 3
(Date:11/25/2009)...Ghrelin, a hormone produced in the stomach, may be...ment of Parkinson,s disease, Yale School of Medici...cent issue of the Journal of Neuroscience . , P...dopamine neurons in an area of the midbrain known ...dopamine production. Reduced production of dopami...
(Date:11/25/2009)...On September 11, firefighters, police officers and...t in the World Trade Center complex. They battled ...arched for survivors, tackled fires and evacuated ...ained an estimated 17,000 people. And making their...ations: frightened workers and their relatives jam...
(Date:11/25/2009)...MADISON, WI, NOVEMBER 25, 2009 Soil is the linchp..., and hydrosphere meet. Despite that, many student... but nothing more. Soil science educators are chal...ublic recognize the critical importance of soil in...soil science and earth science teachers at Univers...
Breaking Biology News(10 mins):Hormone ghrelin can boost resistance to Parkinson's disease 2Magic box for mission impossible 2Magic box for mission impossible 3It's not just dirt! 2Brain Protein Tied to Retardation 59897 1Informed Consent Goes Mobile Helping Patients and Clinicians Cut Confusion and Paperwork 59894 1Informed Consent Goes Mobile Helping Patients and Clinicians Cut Confusion and Paperwork 59894 2Informed Consent Goes Mobile Helping Patients and Clinicians Cut Confusion and Paperwork 59894 3Lake Health Celebrates Grand Opening of TriPoint Medical Center 59890 1Lake Health Celebrates Grand Opening of TriPoint Medical Center 59890 2Lake Health Celebrates Grand Opening of TriPoint Medical Center 59890 3Lake Health Celebrates Grand Opening of TriPoint Medical Center 59890 4Lake Health Celebrates Grand Opening of TriPoint Medical Center 59890 5Lake Health Celebrates Grand Opening of TriPoint Medical Center 59890 6Lake Health Celebrates Grand Opening of TriPoint Medical Center 59890 7
.... , Plant researchers from McGill University an...ounced a major breakthrough in a developmental pro...r the first time the reversal of what is called ep... important to develop a better understanding of ge...anced crops that produce higher yields, are more r...
...nited States that are at the highest risk of susta...enough to the dangers posed by rising temperatures...entury of climate change that has already signific...rns and has already had widespread ecological and ... that the United States will experience at least a...
.... , , Sometimes physicists resort to tried and t...Planck Institute for Metals Research, the Universi...ave constructed micromachines using the same trick...where the masts and rigging of the sailing ship ar...me way, the scientists link the valves, pumps and ...
Other Biology News:Plants display 'molecular amnesia' 2Plants display 'molecular amnesia' 3Most US organizations not adapting to climate change 2Most US organizations not adapting to climate change 3Ship-in-a-bottle kit on a microchip 2Ship-in-a-bottle kit on a microchip 3
...ress Cloning Checker Kits provide two highly effic...fter transformation without time-consuming plasmid...od in Kit I, all you need to do is to transfer par...e transformation plates into the solutions provide...
Mouse Anti-GLP-1 Monoclonal Antibody, Unconjugated, Clone HYB 147-12 from Santa Cruz Biotechnology, Inc.
Rat Anti-p19ARF Monoclonal Antibody, Unconjugated, Clone 5-C3-1 from Upstate
EDTA, tetrasodium salt from GE Healthcare, formerly Amersham Biosciences
Biology Products: